ZD1839 modulates paclitaxel response in renal cancer by blocking paclitaxel-induced activation of the epidermal growth factor receptor-extracellular signal-regulated kinase pathway.

Source:http://linkedlifedata.com/resource/pubmed/id/14760103

Clin. Cancer Res. 2004 Jan 15 10 2 794-801

Download in:

View as

General Info

PMID
14760103